• FirefoxInstall the new Firefox »
  •  Dow Down0.06% Nasdaq Up0.42%

    TG Therapeutics, Inc. (TGTX)

    -NCM
    14.92 Down 0.34(2.23%) 4:00PM EST
    |After Hours : 14.90 Down 0.02 (0.13%) 6:41PM EST
    Add to Portfolio
    Cash FlowGet Cash Flow for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingSep 30, 2014Jun 30, 2014Mar 31, 2014Dec 31, 2013
    Net Income (17,451) (11,986) (7,547) (5,664)
    Operating Activities, Cash Flows Provided By or Used In
    Depreciation61  53  16  1  
    Adjustments To Net Income8,259  8,994  4,187  1,540  
    Changes In Accounts Receivables21  (64)16  (27)
    Changes In Liabilities6,234  848  (4,021)601  
    Changes In Inventories -   -   -   -  
    Changes In Other Operating Activities(5,175)(1,418)(980)(1,361)
    Total Cash Flow From Operating Activities (8,051) (3,573) (8,329) (4,909)
    Investing Activities, Cash Flows Provided By or Used In
    Capital Expenditures(1) -  (3)(2)
    Investments -  (9,218) -  (4,920)
    Other Cash flows from Investing Activities -   -   -   -  
    Total Cash Flows From Investing Activities (1) (9,218) (3) (4,922)
    Financing Activities, Cash Flows Provided By or Used In
    Dividends Paid -   -   -   -  
    Sale Purchase of Stock24,200  273  18,121  133  
    Net Borrowings -   -  (678) -  
    Other Cash Flows from Financing Activities -   -   -   -  
    Total Cash Flows From Financing Activities 24,200   273   17,443   133  
    Effect Of Exchange Rate Changes -   -   -   -  
    Change In Cash and Cash Equivalents 16,148   (12,518) 9,111   (9,698)

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.